Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7640)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2018 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bajer L, Slavcev A, Macinga P, Sticova E, Brezina J, Roder M, Janousek R, Trunecka P, Spicak J, Drastich P. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease. World J Gastroenterol 2018; 24(43): 4939-4949 [PMID: 30487703 DOI: 10.3748/wjg.v24.i43.4939] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i43/4939.htm |
| Number | Citing Articles |
| 1 |
Atsushi Tanaka, Hajime Kono, Patrick S.C. Leung, M. Eric Gershwin. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cellular Immunology 2020; 347: 104021 doi: 10.1016/j.cellimm.2019.104021
|
| 2 |
Atsushi Tanaka, Patrick S.C. Leung, M. Eric Gershwin. Autoimmune Liver Disease. 2020; : 247 doi: 10.1002/9781119532637.ch14
|
| 3 |
Julien Vionnet, Alberto Sanchez-Fueyo, James Neuberger. Liver Immunology. 2020; : 597 doi: 10.1007/978-3-030-51709-0_36
|
| 4 |
Marina Berenguer, Eleonora de Martin, Amelia J. Hessheimer, Josh Levitsky, Daniel G. Maluf, Valeria R. Mas, Nazia Selzner, Helena Hernàndez-Èvole, Alina Lutu, Nabeel Wahid, Haseeb Zubair. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation. Transplant International 2023; 36 doi: 10.3389/ti.2023.11358
|
| 5 |
|
| 6 |
Ari Garber, Miguel Regueiro. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Current Gastroenterology Reports 2019; 21(7) doi: 10.1007/s11894-019-0698-1
|
| 7 |
Chongfa Chen, Ruisheng Ke, Fang Yang, Qiucheng Cai, Jianyong Liu, Xinghua Huang, Jianwei Chen, Fengfeng Xu, Yi Jiang. Risk factors for recurrent autoimmune liver diseases after liver transplantation. Medicine 2020; 99(20): e20205 doi: 10.1097/MD.0000000000020205
|
| 8 |
Romelia Barba Bernal, Esli Medina-Morales, Daniela Goyes, Vilas Patwardhan, Alan Bonder. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021; 2(2): 162 doi: 10.3390/transplantology2020016
|
| 9 |
Yezaz A Ghouri, Veysel Tahan, Bo Shen. Secondary causes of inflammatory bowel diseases. World Journal of Gastroenterology 2020; 26(28): 3998-4017 doi: 10.3748/wjg.v26.i28.3998
|